Th17 cells, in particular, are identified as key effector cells in the chronic inflammatory process of MS, serving as the main source of inflammatory cytokines like IL‐17, IL‐21, and IL‐22 [141]. The gene discussed is IL22; the disease is myeloid sarcoma.